Your account is not claimed yet. You can sign up with ORCID to claim your account.

Shalini Arunogiri

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Venues

The Australian and New Zealand journal of psychiatry

Drug and alcohol review

The Medical journal of Australia

Addiction (Abingdon, England)

Monash University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Monash University

Australia

Lecturer (Adjunct) :: Eastern Health Clinical School

Publications

Anthony Hew, Shalini Arunogiri
Zero alcohol, but not zero risk? The Australian and New Zealand journal of psychiatry (2023)
Natalie Cerocchi, Yvette Mojica-Perez, Michael Livingston, Shalini Arunogiri, Amy Pennay, Sarah Callinan
Examining the association between psychological distress and alcohol use in Australian adolescents over a period of declining consumption. Drug and alcohol review (2023)
Richard Cj Bradlow, Baden Hicks, Temika Mu, Daniel Pham, Michelle Sharkey, Noel Plumley, Dan I Lubman, Shalini Arunogiri
Management of opiate dependence related to dihydrocodeine-sorbitol misuse. The Medical journal of Australia (2023)
Janni K Y Leung, Tesfa Mekonen, XiaoXuan Wang, Shalini Arunogiri, Louisa Degenhardt, Rebecca Mcketin
Methamphetamine exposure and depression-A systematic review and meta-analysis. Drug and alcohol review (2023)
Simon Clay, Zachary Wilkinson, Meredith Ginley, Shalini Arunogiri, Michael Christmass, Dean Membrey, Paul MacCartney, Rachel Sutherland, Samantha Colledge-Frisby, Alison D Marshall, Jack Nagle, Louisa Degenhardt, Michael Farrell, Rebecca Mcketin
Perspectives and sentiments on contingency management from people who use methamphetamine. Drug and alcohol review (2023)
Benjamin Higginbotham, Joahna Kevin Perez, Eva Louie, Paul S Haber, Daniel I Lubman, Shalini Arunogiri, Mary Lou Chatterton, Kirsten C Morley
Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder. The Australian and New Zealand journal of psychiatry (2023)
Rebecca Mcketin, Philip James Clare, David Castle, Alyna Turner, Peter J Kelly, Daniel I Lubman, Shalini Arunogiri, Victoria Manning, Michael Berk
How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: evidence from longitudinal panel data. Addiction (Abingdon, England) (2023)
Shalini Arunogiri, Samantha M Loi
Diversity and retention in academic psychiatry. The Australian and New Zealand journal of psychiatry 56 (9) (2022)
Rowan P Ogeil, Shalini Arunogiri, Vanessa Petersen, James R Gooden, Daniel I Lubman
Sleep disturbance in clients attending a specialist addiction clinic. The American journal on addictions 30 (6) (2021)
Shalini Arunogiri, Rose Crossin, Davinia Rizzo, Leigh C Walker, Kelly Ridley, Caroline T Gurvich
A systematic review of the effect of ovarian sex hormones on stimulant use in females. Addiction biology 26 (6) (2021)
Anthony Hew, Shalini Arunogiri, Dan I Lubman
Challenges in delivering telemedicine to vulnerable populations: experiences of an addiction medical service during COVID-19. The Medical journal of Australia 215 (5) (2021)
Shalini Arunogiri, Rowan Dowling, Vicky Phan, Michelle Sharkey, Temika Mu, Dan I Lubman
Poppy seed tea dependence requiring depot buprenorphine treatment. The Medical journal of Australia (2021)
Rowan P Ogeil, Shalini Arunogiri, Jasmin Grigg
Methamphetamine addiction: do biological rhythms matter, and could they play a role in treatment? Sleep 44 (7) (2021)
Shalini Arunogiri, Suzanne Nielsen
Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence? Drug and alcohol review 39 (3) (2020)
Shalini Arunogiri, Rose Crossin, Debbie Scott, Daniel I Lubman
Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018). Addiction (Abingdon, England) 114 (3) (2019)
Shalini Arunogiri, Foruhar Moayeri, Rose Crossin, Jessica J Killian, Karen Smith, Debbie Scott, Daniel I Lubman
Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia. Addiction (Abingdon, England) 115 (3) (2019)
Shalini Arunogiri, Rebecca Mcketin
Comment on Zang et al 2019: The importance of distinguishing between psychotic and general psychiatric symptoms in the context of methamphetamine use. Addiction biology 25 (2) (2019)
Shalini Arunogiri, James A Foulds, Rebecca McKetin, Dan I Lubman
A systematic review of risk factors for methamphetamine-associated psychosis. The Australian and New Zealand journal of psychiatry 52 (6) (2018)

Shalini Arunogiri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shalini Arunogiri